11 October 2022: Articles
Unknown etiology, Unusual clinical course, Challenging differential diagnosis, Diagnostic / therapeutic accidents, Unusual setting of medical care, Unexpected drug reaction , Educational Purpose (only if useful for a systematic review or synthesis)Jennifer Michelle Stiene1ABCDEF, Patrick William Frank2ABCDEF*
Am J Case Rep 2022; 23:e937450
BACKGROUND: Hyperostosis frontalis interna is a boney overgrowth of the inner side of the frontal bone of the skull caused by overgrowth of the endocranial surface. It is most often found in women after menopause. It is also associated with hormonal imbalance, being overweight, history of headaches, and neurocognitive degenerative conditions. Female gender, advanced age, extended estrogen stimulation, and elevated leptin levels may also play a role. The thickening is usually confined to the frontal bone, but it can spread as far as the anterior parietal and temporal bones.
CASE REPORT: During a medical school dissection course, an extensive boney overgrowth in the frontal regions covering the inside of the frontal bone of the skull of a 90-year-old female donor, who died of a cerebrovascular infarction, was identified. This boney overgrowth was mainly confined within the frontal region, but there was some boney overgrowth that extended to the temporal bones. The overgrowth in the endocranium of the temporal bone was not as severe as the overgrowth of the frontal bone. The morphology of the overgrowth was rigid, uneven, and bumpy. Based upon the physical characteristics, we concluded that this presentation was consistent with hyperostosis frontalis interna.
CONCLUSIONS: Our female donor was found to exhibit a phenomenon which could be clinically underdiagnosed due to its internal nature and asymptomatic presentation. Insight into the potential causes of HFI and its identification during clinical evaluation offers a path for future research to better identify and manage cases of HFI.
Keywords: Calvarial Hyperostosis, Endocrinology, Hyperostosis Frontalis Interna, Menopause, Pathology, Aged, 80 and over, Estrogens, Female, Frontal Bone, Humans, Leptin, Temporal Bone
Hyperostosis frontalis interna (HFI) normally presents with no symptoms and is often an incidental finding when obtaining imaging of the head such as MRI (magnetic resonance imaging), CT (computed tomography) scan, or X-ray . HFI is described as a boney overgrowth of the frontal bone and can sometimes spread to the temporal or parietal bones. There are different classifications when diagnosing HFI and they are described as “types” dependent on the extent of involvement, appearance, shape, border, and involvement of other bones . According to Hershkovitz et al, the 4 distinct types are classified as A, B, C, or D. They describe the morphology of the calvarium and what percent is covered with boney overgrowth; 25%, 50%, or more than 50% for types B, C, and D, respectively. Type A is just based on isolated small overgrowths covering less than 25% of the frontal bone . This disorder presents most often among the middle-aged and elderly, especially females, and the severity has been shown to increase with age [2,4]. HFI has presented in many different cases of women who are post-menopausal, people who are obese, have endocrine abnormalities, hirsutism, chronic headaches, seizures, or dementia [1,5]. When this condition occurs in males, some cases had an increase in androgen stimulation . HFI has also been linked to increased levels of leptin, which is higher in females more than males, and is associated with high body mass index and obesity . As the severity of HFI increases, progressive compression of the dura mater can cause decreased blood supply to the meninges and certain regions of the frontal lobe, including Broca’s speech area, the premotor cortex, and the prefrontal association cortex, may further result in headaches and impairment of cognition and memory .
In the absence of any standard therapy for this rare condition, supportive care with pain management is suggested . Best practice management of HFI begins with patient counseling about the diagnosis and outlining a plan of treatment of headache pain. Treatment is mainly supportive. Prompt diagnosis helps to prevent a misdiagnosis and prevent the patient from undergoing many unnecessary diagnostic tests . When HFI is associated with secondary conditions (eg, seizure or Morgagni-Stewart-Morel syndrome), management should be focused on treatment of the secondary condition .
This case comes from a 90-year-old woman who graciously donated her body to the University of Toledo College of Medicine and Life Sciences donor program. The patient died due to a cerebrovascular infarction. All other details of her past medical history were not available to us due to the anonymity of the donor program. When opening the cranium for dissection, our dissection team noticed that the surface of the endocranium was rough and bumpy (Figure 1). This growth of bone was not present throughout the skull and was mainly localized to the frontal bone with just some overgrowth in the temporal bones. The frontal bone was significantly thicker than the parietal, temporal, and occipital bones (Figure 2). This overgrowth of bone in the cranium is called hyperostosis frontalis interna. Using the classification system of Hershkovitz et al, it appears that most of the frontal bone and endocranium is involved, or more than 50%, making this type D . It is also important to note that the overgrowth does not cross the calvaria midline, which is another defining feature of HFI .
There are multiple case reports of hyperostosis frontalis interna (HFI). However, there are no concrete data that show why this occurs. Our goal here is to discuss possible avenues to open the doors for more research to discover the mechanisms involved in this clinical presentation.
Due to the asymptomatic nature of this disease, it is often undiscovered or discovered as an incidental finding . Other than the fact that it can go undetected, it does share some principal findings with other illnesses, giving it the possibility to be underdiagnosed or misdiagnosed . One disease, for example, is osteitis deformans (Paget’s disease), which is a pathologic thickening of bones such as the skull, spine, and pelvis. This disease occurs mainly in the middle-age to elderly population and accounts for 1% of the population. This classically presents with a thickening of the skull and often does not have symptoms. Most people notice a change in hat size and if it does progress it can eventually cause hearing loss if the petrous part of the temporal bone impinges the vestibulocochlear nerve . The major difference of this presentation is the location being in the temporal bone. Also, in Paget’s disease, the bone is brittle due to the pathology of the osteo-blasts and osteoclasts at work. In HFI, the bone is not brittle and is exceptionally durable.
A second condition – osteomatosis (Leontiasis Ossea or Virchow’s Disease) – can also mimic HFI. Osteomatosis is a hereditary disorder that involves the membranous bone of the skull. This disease involves significant thickening of the cranial bones, especially the maxilla, mandible, and frontal and temporal bones. A case study by Plenk and Garnder  of a family with a high incidence of colonic polyposis identified a connection between the large-bowel lesions and bony tumors of the face and scalp in the same individuals. While the process of bony growth can begin in early adolescence, the growth is slow and may go unnoticed for many years. Knowledge of these conditions could be critical when diagnosing a patient so that it is not misdiagnosed.
Further investigation may establish a correlation between different pathologies and HFI, so physicians are more aware to make the diagnosis. There are many reports of different hormonal imbalances that also report instances of HPI in those patients. In one study (n=36), 72% of patients who had acromegaly had HFI, and of those, 19 had hyperprolactinemia . The acromegalic patients who had hyperprolactinemia also had higher evidence of HPI than those in the normal control groups. The experimental results support that HPI can be a marker of pituitary disfunction . Another case report, from Yamakawa et al , discusses a male with atrophied gonads who also had HPI, which further supports the idea that HPI could be due to gonadal imbalances.
Due to the lack of consensus for the cause of hyperostosis frontalis interna, we discussed different avenues that could be addressed in future research on this rare finding. There are many endocrine-driven pathways that could be explored assess impact on patients with HFI, such as case reports on people with Klinefelter’s syndrome, acromegaly, and trauma, and those with atrophied gonads. Furthermore, if insulin and lifestyle are correlated with HFI in archeologic findings, then it could be useful to investigate current populations and conduct case studies to see if those with type 2 diabetes mellitus are developing HFI later in life. HFI is not routinely considered as a cause of patient symptoms . If HFI is better known in the world of clinical medicine, this diagnosis can be made more effectively, and patient education and treatment would be timelier and focused. Lastly, if insulin resistance is correlated with HFI, then we should see an increase in cases of HFI in the future with regards to obesity prevalence in the United States, which makes it even more important for those to become aware of this diagnosis.
1.. She R, Szakacs J, Hyperostosis frontalis interna: Case report and review of literature: Ann Clin Lab Sci, 2004; 34(2); 206-8
2.. Cvetković D, Nikolić S, Brković V, Hyperostosis frontalis interna as an age-related phenomenon – differences between males and females and possible use in identification: Sci Justice, 2019; 9(2); 172-76
3.. Hershkovitz I, Greenwald C, Rothschild BM, Hyperostosis frontalis inter-na: An anthropological perspective: Am J Phys Anthropol, 1999; 109; 303-25
4.. Yamakawa K, Mizutani K, Takahashi M, Hyperostosis frontalis interna associated with hypogonadism in an elderly man: Age and ageing, 2006; 35(2); 202-3
5.. Talarico EF, Prather AD, Hardt KD, A case of extensive hyperostosis frontalis interna in an 87-year-old female human cadaver: Clin Anat, 2008; 21(3); 259-68
6.. Rühil F, Henneberg M, Are Hyperostosis frontalis interna and leptin linked? A hypothetical approach about hormonal influence on human microevolution: Medical Hypotheses, 2002; 58(5); 378-81
7.. Torrealba-Acosta G, Mandel J, Hyperostosis frontalis interna diagnosed after a provoked seizure: BMJ Case Rep, 2020; 13; e236520
8.. , 2007 Available from:https://rarediseases.org/rare-diseases/hyperostosis-frontalis-interna/
9.. Penk HP, Gardner EJ, Osteomatosis (leontiasis ossea): Hereditary disease of membranous bone formation associated in one family with polyposis of the colon: Radiology, 1954; 62(6); 830-40
10.. Priyambada P, Joshi K, Ozdemir B, Hyperostosis frontalis interna (HFI): A case report and review of literature: Case Reports in Internal Medicine, 2017; 4(1); 57-59
11.. Szeniczey T, Marcsik A, Ács Z, Hyperostosis frontalis interna in ancient populations from the Carpathian Basin – a possible relationship between lifestyle and risk of development: Int J Paleopathol, 2019; 24; 108-18
12.. : Adult Obesity Facts, Centers for Disease Control and prevention Updated May 17, 2022. Available from: https://www.cdc.gov/obesity/data/adult.html
13.. Elghazouani F, Schizophrenia and hyperostosis frontalis interna with history of head injury: Case Rep Med, 2021; 2021; 6634640
14.. Ramchandren S, Liebeskind DS, Headache in a patient with Klinefelter’s syndrome and hyperostosis frontalis interna: J Headache Pain, 2007; 8(6); 342-44
04 Oct 2023 : Clinical ResearchA Retrospective Study of 205 Patients with Complex Kidney Stones to Compare Outcomes from Super-Mini Percut...
Med Sci Monit In Press; DOI: 10.12659/MSM.941012
03 Oct 2023 : Clinical ResearchPrevalence and Risk Factors for Modic Changes in Symptomatic Cervical Ossification of the Posterior Longitu...
Med Sci Monit In Press; DOI: 10.12659/MSM.941674
03 Oct 2023 : Clinical ResearchTime-Dependent Factors Influencing Cardiocerebral Vascular Events in Chronic Hemodialysis Patients: Insight...
Med Sci Monit In Press; DOI: 10.12659/MSM.941553
Most Viewed Current Articles
13 Nov 2021 : Clinical ResearchAcceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical ResearchRetrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...
Med Sci Monit 2021; 27:e935379
14 Dec 2022 : Clinical ResearchPrevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels
Med Sci Monit 2022; 28:e937990
08 Mar 2022 : Review articleA Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...
Med Sci Monit 2022; 28:e936292